Dosing & Uses
Mydriasis Reversal
Pending FDA approval for reversal of pharmacologically-induced mydriasis produced by adrenergic agonist (eg, phenylephrine) or parasympatholytic (eg, tropicamide) agents, a combination of both
Next:
Pharmacology
Mechanism of Action
Nonselective alpha adrenergic antagonist that inhibits the contraction of smooth muscle of the iris
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
